300404 Boji Medical Technology
- 7.65
- +0.14+1.86%
Boji Medical Technology News
Boji Pharmaceutical: Progress Announcement on the Use of Temporarily Idle Raised Funds for Cash Management, Expiration, and Continued Cash Management
Boji Pharmaceutical: Guangfa Securities Co., Ltd.\'s 2024 semi-annual continuous supervision and follow-up report on the company
Boji Pharmaceutical: Legal Opinion of Beijing Kangda (Guangzhou) Law Firm on the Company\'s 2024 Second Shareholders\' Meeting
Boji Pharmaceuticals: Notice to creditors on the repurchase and cancellation of some restricted shares
Boji Pharmaceutical: Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders
Broge Pharmaceuticals: Announcement on the completion of cancellation of some stock options
Boji Pharmaceutical: Announcement on the completion of sales of some special fund-raising accounts
Boji Pharmaceutical: Announcement on the completion of private equity fund filing by Boqi Investment Fund
Boji Pharmaceuticals: 300404 Boji Pharmaceuticals Investor Relations Management Information 20240828
Boji Pharmaceutical: Notice on Using Temporarily Idle Raised Funds for Cash Management
Broge Pharmaceuticals: Announcement on the Repurchase, Cancellation and Cancellation of Certain Restricted Shares
Boji Pharmaceutical: Special Report on the Deposit and Use of Funds Raised for the Semi-Annual Year 2024
Boji Pharmaceutical: Beijing Kangda (Guangzhou) Law Firm\'s Legal Opinion on the Company\'s Cancellation of Some Stock Options
Boji Pharmaceutical: Opinions of Guangfa Securities Co., Ltd. on the Company\'s Use of Temporarily Idle Own Funds for Cash Management
Boji Pharmaceutical: Notice on increasing the number of insured persons within the guarantee amount of the company\'s business contract
Boji Pharmaceuticals: Announcement of Board Resolutions
Boji Pharmaceuticals: Announcement on Proposed Renewal of the Accounting Firm
Boji Pharmaceuticals: Announcement on Accruing Asset Impairment Losses, Credit Impairment Losses, and Asset Write-off
Broge Pharmaceuticals: 2024 Semi-Annual Report Summary
Boji Pharmaceuticals: Announcement of Supervisory Board Resolutions
Analysis
Price Target
No Data
No Data